Opiant Pharmaceuticals, Inc.
Save
108.80M
Market cap
–
Current P/E
26.74x
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders.
Similar securities
Based on sector and market capitalization
Report issue